Alicia Morgans on Transitions in Treating mCRPC: Abiraterone after Sipuleucel-T

Transitions in Treating mCRPC: Abiraterone after Sipuleucel-T

Alicia Morgans, MD presents the treatment of a prostate cancer patient throughout a period of disease progression, and provides the rationale for patient selection and drug selection for treatments.

Alicia K. Morgans, MD
Assistant Professor of Medicine
Vanderbilt University Medical Center

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe